Atara Biotherapeutics, Inc.
ATRA
$7.42
$0.101.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.75% | 90.38% | -23.67% | -10.61% | -49.49% |
| Total Receivables | 11.01% | -44.88% | -93.28% | 5.65% | 5,958.26% |
| Inventory | -23.78% | -25.44% | 16.57% | 65.71% | 47.26% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.73% | 57.24% | -26.37% | 27.60% | -30.70% |
| Total Current Assets | -29.35% | 47.18% | -41.36% | 4.48% | -14.18% |
|
|
|||||
| Total Current Assets | -29.35% | 47.18% | -41.36% | 4.48% | -14.18% |
| Net Property, Plant & Equipment | -13.46% | -7.36% | -6.74% | -6.50% | -7.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.57% | -6.98% | -6.70% | -20.15% | -22.98% |
| Total Assets | -23.55% | 21.68% | -29.04% | -0.14% | -12.33% |
|
|
|||||
| Total Accounts Payable | 103.49% | -59.15% | 84.06% | -22.53% | -43.42% |
| Total Accrued Expenses | -7.15% | 6.52% | -47.27% | -16.24% | 1.80% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.06% | 4.71% | -0.24% | 15.21% | -8.40% |
| Total Finance Division Other Current Liabilities | -18.27% | 8.14% | -12.64% | 58.23% | 570.34% |
| Total Other Current Liabilities | -18.27% | 8.14% | -12.64% | 58.23% | 570.34% |
| Total Current Liabilities | -13.72% | 5.20% | -17.94% | 27.04% | 79.83% |
|
|
|||||
| Total Current Liabilities | -13.72% | 5.20% | -17.94% | 27.04% | 79.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.58% | -8.94% | -8.28% | -7.65% | -5.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.12% | 2.04% | 1.20% | -47.03% | -31.43% |
| Total Liabilities | -11.52% | 2.23% | -13.44% | -0.44% | 10.48% |
|
|
|||||
| Common Stock & APIC | 0.31% | 2.21% | 0.34% | 1.74% | 0.63% |
| Retained Earnings | -0.62% | -1.08% | -0.95% | -1.61% | -3.17% |
| Treasury Stock & Other | -63.64% | 257.14% | 74.55% | 73.04% | 64.27% |
| Total Common Equity | -7.45% | 18.34% | -12.78% | 0.93% | -95.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.45% | 18.34% | -12.78% | 0.93% | -95.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.45% | 18.34% | -12.78% | 0.93% | -95.19% |
|
|
|||||